Your browser doesn't support javascript.
loading
Type 1 Diabetes Genetic Risk in 109,954 Veterans With Adult-Onset Diabetes: The Million Veteran Program (MVP).
Yang, Peter K; Jackson, Sandra L; Charest, Brian R; Cheng, Yiling J; Sun, Yan V; Raghavan, Sridharan; Litkowski, Elizabeth M; Legvold, Brian T; Rhee, Mary K; Oram, Richard A; Kuklina, Elena V; Vujkovic, Marijana; Reaven, Peter D; Cho, Kelly; Leong, Aaron; Wilson, Peter W F; Zhou, Jin; Miller, Donald R; Sharp, Seth A; Staimez, Lisa R; North, Kari E; Highland, Heather M; Phillips, Lawrence S.
Affiliation
  • Yang PK; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
  • Jackson SL; Atlanta Veterans Administration Medical Center, Atlanta, GA.
  • Charest BR; Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.
  • Cheng YJ; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
  • Sun YV; Massachusetts Veterans Epidemiology Research and Information Center, Boston, MA.
  • Raghavan S; Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
  • Litkowski EM; Atlanta Veterans Administration Medical Center, Atlanta, GA.
  • Legvold BT; Rollins School of Public Health, Emory University, Atlanta, GA.
  • Rhee MK; Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO.
  • Oram RA; University of Colorado School of Medicine, Denver, CO.
  • Kuklina EV; Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO.
  • Vujkovic M; University of Colorado School of Medicine, Denver, CO.
  • Reaven PD; Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
  • Cho K; Atlanta Veterans Administration Medical Center, Atlanta, GA.
  • Leong A; Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
  • Wilson PWF; College of Medicine and Health, University of Exeter Medical School, Devon, U.K.
  • Zhou J; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
  • Miller DR; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Sharp SA; Phoenix Veterans Affairs Health Care System, Phoenix, AZ.
  • Staimez LR; Massachusetts Veterans Epidemiology Research and Information Center, Boston, MA.
  • North KE; Brigham and Women's Hospital, Boston, MA.
  • Highland HM; Harvard Medical School, Boston, MA.
  • Phillips LS; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA.
Diabetes Care ; 47(6): 1032-1041, 2024 Jun 01.
Article in En | MEDLINE | ID: mdl-38608262
ABSTRACT

OBJECTIVE:

To characterize high type 1 diabetes (T1D) genetic risk in a population where type 2 diabetes (T2D) predominates. RESEARCH DESIGN AND

METHODS:

Characteristics typically associated with T1D were assessed in 109,594 Million Veteran Program participants with adult-onset diabetes, 2011-2021, who had T1D genetic risk scores (GRS) defined as low (0 to <45%), medium (45 to <90%), high (90 to <95%), or highest (≥95%).

RESULTS:

T1D characteristics increased progressively with higher genetic risk (P < 0.001 for trend). A GRS ≥90% was more common with diabetes diagnoses before age 40 years, but 95% of those participants were diagnosed at age ≥40 years, and their characteristics resembled those of individuals with T2D in mean age (64.3 years) and BMI (32.3 kg/m2). Compared with the low-risk group, the highest-risk group was more likely to have diabetic ketoacidosis (low GRS 0.9% vs. highest GRS 3.7%), hypoglycemia prompting emergency visits (3.7% vs. 5.8%), outpatient plasma glucose <50 mg/dL (7.5% vs. 13.4%), a shorter median time to start insulin (3.5 vs. 1.4 years), use of a T1D diagnostic code (16.3% vs. 28.1%), low C-peptide levels if tested (1.8% vs. 32.4%), and glutamic acid decarboxylase antibodies (6.9% vs. 45.2%), all P < 0.001.

CONCLUSIONS:

Characteristics associated with T1D were increased with higher genetic risk, and especially with the top 10% of risk. However, the age and BMI of those participants resemble those of people with T2D, and a substantial proportion did not have diagnostic testing or use of T1D diagnostic codes. T1D genetic screening could be used to aid identification of adult-onset T1D in settings in which T2D predominates.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Veterans / Diabetes Mellitus, Type 1 Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Veterans / Diabetes Mellitus, Type 1 Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 2024 Document type: Article Country of publication: